Skip to main content

Table 2 Clinical related characteristics of HIV infected patients treated at Woldia and Dessie hospitals, 2018

From: Predictors of virological treatment failure among adult HIV patients on first-line antiretroviral therapy in Woldia and Dessie hospitals, Northeast Ethiopia: a case-control study

Variables Category Cases(n=154) Controls (n=154) p-value for Chi-square test
Frequency (%) Frequency (%)
Baseline body mass index (BMI ) <16 14 (9.1) 16 (10.4) 0.349
16-18.5 44 (28.6) 33 (21.4)
>18.5 96 (62.3) 105 (68.2)
Current BMI <16 27 (17.5) 10 (6.5) < 0.001
16-18.5 37 (24) 12 (7.8)
>18.5 90 (58.4) 132 (85.7)
Baseline CD4 T-cell count ≤ 200 98 (63.6) 91 (59.1) 0.413
>200 56 (36.4) 63 (40.9)
Current CD4 T-cell count ≤ 200 62 (40.3) 30 (19.5) <0.001
>200 92 (59.7) 124 (80.5)
Base line Hgb(g/dl) ≤12 51 (33.1) 43 (27.9) 0.322
>12 103 (66.9) 111 (72.1)
Functional status Working 85 (55.2) 89 (57.8) 0.295
Ambulatory 64 (41.6) 55 (35.7)
Bedridden 5 (3.2) 10 (6.5)
WHO staging at baseline stage 1 17 (11) 27 (17.5) 0.347
stage 2 57 (37) 50 (32.5)
stage 3 66 (42.9) 60 (39)
stage 4 14 (9.1) 17 (11)
Treatment staginga T1 stage 140 (90.9) 135 (87.7) 0.643
T2 stage 10 (6.5) 13 (8.4)
T3 stage 4 (2.6) 6 (3.9)
HIV durationb <24 months 7 (4.5) 7 (4.5) 0.985
24-48 months 19 (12.3) 20 (13)
>48 months 128 (83) 127 (82.5)
TB before starting ART Yes 28 (18.2) 34 (22) 0.394
No 126 (81.8) 120 (78)
TB after starting ART Yes 3 (2) 2 (1.3) 0.652
No 151 (98) 152 (98.7)
  1. aClinical stage of HIV patients after starting antiretroviral treatment
  2. bthe time includes both before and after starting ART following first HIV positive test